HEADER PROTEIN BINDING 11-MAY-10 2KXQ TITLE SOLUTION STRUCTURE OF SMURF2 WW2 AND WW3 BOUND TO SMAD7 PY MOTIF TITLE 2 CONTAINING PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: E3 UBIQUITIN-PROTEIN LIGASE SMURF2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HSMURF2, SMAD UBIQUITINATION REGULATORY FACTOR 2, SMAD- COMPND 5 SPECIFIC E3 UBIQUITIN-PROTEIN LIGASE 2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: SMAD7 PY MOTIF CONTAINING PEPTIDE; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SMURF2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21DE3 CP; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6P1; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: SMAD7; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21DE3 CP; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PGEX6P1 KEYWDS WW, PY MOTIF, SMURF2, TGF-BETA, MODULAR BINDING, PROTEIN BINDING EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.CHONG,H.LIN,J.WRANA,J.D.FORMAN-KAY REVDAT 4 01-MAY-24 2KXQ 1 SEQADV REVDAT 3 20-JUN-12 2KXQ 1 JRNL VERSN REVDAT 2 27-OCT-10 2KXQ 1 REMARK REVDAT 1 13-OCT-10 2KXQ 0 JRNL AUTH P.A.CHONG,H.LIN,J.L.WRANA,J.D.FORMAN-KAY JRNL TITL COUPLING OF TANDEM SMAD UBIQUITINATION REGULATORY FACTOR JRNL TITL 2 (SMURF) WW DOMAINS MODULATES TARGET SPECIFICITY. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 18404 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20937913 JRNL DOI 10.1073/PNAS.1003023107 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER, A.T. ET AL. REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2KXQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1000101704. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.2 REMARK 210 IONIC STRENGTH : 235 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1.2 MM [U-100% 13C; U-100% 15N] REMARK 210 WW23, 1.2 MM [U-100% 13C; U-100% REMARK 210 15N] S7PY, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D CBCA(CO)NH; 3D HNCACB; 3D REMARK 210 HCCH-TOCSY; 3D NC-NOESY (N AND C REMARK 210 SIMULTANEOUS); HACAN; 3D CCC- REMARK 210 TOCSY-NNH; HBCBCGCDHD_ARO; REMARK 210 HBCBCGCDCDHE_ARO REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : INOVA REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O THR A 262 H GLY A 265 1.46 REMARK 500 O THR A 308 H GLY A 311 1.52 REMARK 500 O CYS A 293 H GLY A 297 1.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO A 251 35.21 -83.10 REMARK 500 1 PRO A 254 -166.89 -66.32 REMARK 500 1 GLN A 263 -59.65 -17.51 REMARK 500 1 TYR A 314 -158.07 -137.20 REMARK 500 1 ARG A 321 74.51 48.12 REMARK 500 1 SER B 202 -179.43 62.47 REMARK 500 1 LEU B 204 52.24 -156.54 REMARK 500 1 PRO B 207 -78.52 -90.38 REMARK 500 1 PRO B 210 159.60 -36.43 REMARK 500 1 SER B 212 39.43 168.60 REMARK 500 1 ARG B 213 -29.01 75.32 REMARK 500 1 PRO B 215 90.58 -51.17 REMARK 500 2 PRO A 251 41.37 -86.75 REMARK 500 2 ASP A 252 81.72 63.30 REMARK 500 2 GLU A 255 127.53 63.28 REMARK 500 2 GLN A 263 -40.52 -29.00 REMARK 500 2 TYR A 314 -159.84 -136.26 REMARK 500 2 ARG A 321 73.98 55.91 REMARK 500 2 SER A 331 -32.53 -39.60 REMARK 500 2 ALA A 332 52.78 -115.47 REMARK 500 2 LEU B 200 155.99 60.46 REMARK 500 2 SER B 202 -178.02 -69.07 REMARK 500 2 GLU B 205 156.49 62.53 REMARK 500 2 PRO B 207 -74.11 -73.25 REMARK 500 2 PRO B 210 158.81 -32.32 REMARK 500 2 SER B 212 30.85 170.92 REMARK 500 2 ARG B 213 -20.18 72.37 REMARK 500 3 PRO A 251 35.73 -86.17 REMARK 500 3 PRO A 254 -164.43 -53.49 REMARK 500 3 GLN A 263 -43.51 -25.20 REMARK 500 3 SER A 289 -56.82 -126.84 REMARK 500 3 TYR A 314 -154.39 -141.11 REMARK 500 3 ARG A 321 75.40 46.02 REMARK 500 3 PRO B 207 -74.52 -87.74 REMARK 500 3 PRO B 210 164.11 -40.02 REMARK 500 3 SER B 212 36.67 177.14 REMARK 500 3 ARG B 213 -22.25 71.38 REMARK 500 3 PRO B 215 80.77 -63.60 REMARK 500 4 LEU A 246 -71.76 -154.38 REMARK 500 4 ASP A 252 67.34 64.21 REMARK 500 4 GLU A 255 115.81 58.88 REMARK 500 4 GLN A 263 -54.73 15.62 REMARK 500 4 TYR A 314 -158.84 -143.34 REMARK 500 4 ARG A 321 73.90 43.09 REMARK 500 4 ALA A 332 68.98 -105.39 REMARK 500 4 PRO B 199 32.73 -89.96 REMARK 500 4 PRO B 210 162.41 -31.88 REMARK 500 4 SER B 212 41.82 163.65 REMARK 500 4 ARG B 213 -28.83 72.73 REMARK 500 5 PRO A 245 42.31 -87.12 REMARK 500 REMARK 500 THIS ENTRY HAS 133 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 PEPTIDE SEQUENCE ELESPPPPYSRYPMD CORRESPONDS TO RESIDUES 203-217 OF REMARK 999 UNIPROT ENTRY O15105. DBREF 2KXQ A 250 333 UNP Q9HAU4 SMUF2_HUMAN 250 333 DBREF 2KXQ B 198 217 PDB 2KXQ 2KXQ 198 217 SEQADV 2KXQ GLY A 244 UNP Q9HAU4 EXPRESSION TAG SEQADV 2KXQ PRO A 245 UNP Q9HAU4 EXPRESSION TAG SEQADV 2KXQ LEU A 246 UNP Q9HAU4 EXPRESSION TAG SEQADV 2KXQ GLY A 247 UNP Q9HAU4 EXPRESSION TAG SEQADV 2KXQ GLY A 248 UNP Q9HAU4 EXPRESSION TAG SEQADV 2KXQ SER A 249 UNP Q9HAU4 EXPRESSION TAG SEQRES 1 A 90 GLY PRO LEU GLY GLY SER PRO PRO ASP LEU PRO GLU GLY SEQRES 2 A 90 TYR GLU GLN ARG THR THR GLN GLN GLY GLN VAL TYR PHE SEQRES 3 A 90 LEU HIS THR GLN THR GLY VAL SER THR TRP HIS ASP PRO SEQRES 4 A 90 ARG VAL PRO ARG ASP LEU SER ASN ILE ASN CYS GLU GLU SEQRES 5 A 90 LEU GLY PRO LEU PRO PRO GLY TRP GLU ILE ARG ASN THR SEQRES 6 A 90 ALA THR GLY ARG VAL TYR PHE VAL ASP HIS ASN ASN ARG SEQRES 7 A 90 THR THR GLN PHE THR ASP PRO ARG LEU SER ALA ASN SEQRES 1 B 20 GLY PRO LEU GLY SER GLU LEU GLU SER PRO PRO PRO PRO SEQRES 2 B 20 TYR SER ARG TYR PRO MET ASP HELIX 1 1 ASN A 292 LEU A 296 5 5 SHEET 1 A 3 GLU A 258 THR A 262 0 SHEET 2 A 3 GLN A 266 HIS A 271 -1 O LEU A 270 N GLU A 258 SHEET 3 A 3 VAL A 276 THR A 278 -1 O THR A 278 N PHE A 269 SHEET 1 B 3 ILE A 305 ASN A 307 0 SHEET 2 B 3 VAL A 313 ASP A 317 -1 O TYR A 314 N ARG A 306 SHEET 3 B 3 THR A 322 GLN A 324 -1 O GLN A 324 N PHE A 315 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1